share_log

Some Scilex Holding Company (NASDAQ:SCLX) Analysts Just Made A Major Cut To Next Year's Estimates

Some Scilex Holding Company (NASDAQ:SCLX) Analysts Just Made A Major Cut To Next Year's Estimates

一些 Scilex Holding 公司 (納斯達克代碼:SCLX) 的分析師剛剛大幅削減了明年的預估
Simply Wall St ·  06/14 19:46

The analysts covering Scilex Holding Company (NASDAQ:SCLX) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Both revenue and earnings per share (EPS) estimates were cut sharply as analysts factored in the latest outlook for the business, concluding that they were too optimistic previously. Surprisingly the share price has been buoyant, rising 26% to US$1.49 in the past 7 days. With such a sharp increase, it seems brokers may have seen something that is not yet being priced in by the wider market.

今天,覆蓋Scilex Holding Company(NASDAQ:SCLX)的分析師對今年的法定業績預測進行了顯著修訂,向股東們傳遞了一定的負面消息。分析師們大幅下調了營業收入和每股收益(EPS)的預期,將最新的業務前景計入其中,得出他們先前過於樂觀的結論。令人驚訝的是,股價一直保持強勁,過去7天上漲了26%,達到了1.49美元。因此,經紀人們可能已經看到了更廣泛市場尚未定價的某些東西。

Following the downgrade, the current consensus from Scilex Holding's three analysts is for revenues of US$58m in 2024 which - if met - would reflect a substantial 24% increase on its sales over the past 12 months. The loss per share is anticipated to greatly reduce in the near future, narrowing 47% to US$0.71. However, before this estimates update, the consensus had been expecting revenues of US$72m and US$0.47 per share in losses. Ergo, there's been a clear change in sentiment, with the analysts administering a notable cut to this year's revenue estimates, while at the same time increasing their loss per share forecasts.

降級後,Scilex Holding的三位分析師目前的共識是,2024年銷售額將達到5,800萬美元,如果實現,將反映出該公司過去12個月銷售額的大幅增長24%。每股虧損預計將在不久的將來大幅減少,降幅爲47%至0.71美元。然而,在這些預期更新之前,共識一直期望營業額爲7,200萬美元,每股虧損爲0.47美元。因此,情緒發生了明顯變化,分析師們在今年的營收預期上做出了顯著調整,同時增加了每股虧損的預測。

earnings-and-revenue-growth
NasdaqCM:SCLX Earnings and Revenue Growth June 14th 2024
納斯達克CM:SCLX營收和收益增長2024年6月14日

There was no major change to the consensus price target of US$5.33, signalling that the business is performing roughly in line with expectations, despite lower earnings per share forecasts.

共識價格目標未發生重大變化,爲5.33美元,表明企業表現大致符合預期,儘管每股收益預測較低。

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's clear from the latest estimates that Scilex Holding's rate of growth is expected to accelerate meaningfully, with the forecast 34% annualised revenue growth to the end of 2024 noticeably faster than its historical growth of 13% over the past year. Compare this with other companies in the same industry, which are forecast to grow their revenue 10% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Scilex Holding to grow faster than the wider industry.

我們可以以更寬廣的視角來看待這些預測,比如與過去的業績相比如何,與同行業其他公司相比,預測是否更加看好或悲觀等。從最新的預測來看,Scilex Holding的增長速度預計會明顯加速,到2024年年底,預計年化營收增長率將達到34%,明顯快於過去一年13%的歷史增長率。相比之下,同行業其他公司的營收預計每年增長10%。因此,儘管增長前景比最近過去的更加光明,分析師們也預計Scilex Holding會比更廣泛的行業增長得更快。

The Bottom Line

最重要的事情是分析師增加了它對下一年每股虧損的估計。令人欣慰的是,營收預測未發生重大變化,業務仍有望比整個行業增長更快。共識價格目標穩定在28.50美元,最新估計不足以對價格目標產生影響。

The most important thing to note from this downgrade is that the consensus increased its forecast losses this year, suggesting all may not be well at Scilex Holding. While analysts did downgrade their revenue estimates, these forecasts still imply revenues will perform better than the wider market. The lack of change in the price target is puzzling in light of the downgrade but, with a serious decline expected this year, we wouldn't be surprised if investors were a bit wary of Scilex Holding.

從這次降級的最重要的事情來看,共識增加了今年的虧損預期,這表明Scilex Holding未必一切都好。雖然分析師們下調了他們的營收預測,但這些預測仍表明營收將表現得比更廣泛的市場更好。鑑於這次降級,價格目標的缺乏變化並令人困惑。但考慮到今年將面臨嚴重的下降,我們不會對Scilex Holding的投資者們感到有些擔憂。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Scilex Holding going out to 2026, and you can see them free on our platform here.

與明年相比,公司收益的長期趨勢更加重要。在Simply Wall St,我們有關於Scilex Holding的分析師全方位的預測,可以在這裏免費查看。

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks with high insider ownership.

當然,看到公司管理層投入大量資金投資股票的情況與分析師是否對其評級下調一樣有用。因此,您還可以搜索此處的高內部所有權股票的免費列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論